| abstract |
The present disclosure provides compositions and methods for their use in the treatment of insulin deficiency (ID) condition, or an associated symptom, in a subject in need thereof, the compositions comprising a S100 calcium -binding protein A9 (S100A9), a variant or a fragment thereof and insulin, a variant or a fragment thereof. |